India · Delayed Price · Currency is INR Suven Life Sciences Statistics
Total Valuation
BOM:530239 has a market cap or net worth of INR 75.68 billion. The enterprise value is 70.67 billion.
| Market Cap | 75.68B |
| Enterprise Value | 70.67B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:530239 has 282.56 million shares outstanding. The number of shares has increased by 9.53% in one year.
| Current Share Class | 282.56M |
| Shares Outstanding | 282.56M |
| Shares Change (YoY) | +9.53% |
| Shares Change (QoQ) | +16.81% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 2.74% |
| Float | 97.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 858.70 |
| PB Ratio | 12.80 |
| P/TBV Ratio | 12.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.16, with a Debt / Equity ratio of 0.03.
| Current Ratio | 29.16 |
| Quick Ratio | 28.01 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -587.28 |
Financial Efficiency
Return on equity (ROE) is -78.80% and return on invested capital (ROIC) is -413.71%.
| Return on Equity (ROE) | -78.80% |
| Return on Assets (ROA) | -47.69% |
| Return on Invested Capital (ROIC) | -413.71% |
| Return on Capital Employed (ROCE) | -47.85% |
| Weighted Average Cost of Capital (WACC) | 9.15% |
| Revenue Per Employee | 620,690 |
| Profits Per Employee | -24.82M |
| Employee Count | 142 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.76% in the last 52 weeks. The beta is 0.89, so BOM:530239's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | +35.76% |
| 50-Day Moving Average | 335.28 |
| 200-Day Moving Average | 245.20 |
| Relative Strength Index (RSI) | 29.96 |
| Average Volume (20 Days) | 45,228 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:530239 had revenue of INR 88.14 million and -3.52 billion in losses. Loss per share was -14.74.
| Revenue | 88.14M |
| Gross Profit | 81.82M |
| Operating Income | -3.72B |
| Pretax Income | -3.52B |
| Net Income | -3.52B |
| EBITDA | -3.67B |
| EBIT | -3.72B |
| Loss Per Share | -14.74 |
Balance Sheet
The company has 5.18 billion in cash and 166.94 million in debt, with a net cash position of 5.01 billion or 17.75 per share.
| Cash & Cash Equivalents | 5.18B |
| Total Debt | 166.94M |
| Net Cash | 5.01B |
| Net Cash Per Share | 17.75 |
| Equity (Book Value) | 5.91B |
| Book Value Per Share | 22.43 |
| Working Capital | 5.28B |
Cash Flow
In the last 12 months, operating cash flow was -3.01 billion and capital expenditures -50.83 million, giving a free cash flow of -3.06 billion.
| Operating Cash Flow | -3.01B |
| Capital Expenditures | -50.83M |
| Depreciation & Amortization | 51.88M |
| Net Borrowing | -3.73M |
| Free Cash Flow | -3.06B |
| FCF Per Share | -10.85 |
Margins
| Gross Margin | 92.83% |
| Operating Margin | -4,223.81% |
| Pretax Margin | -3,998.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:530239 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.53% |
| Shareholder Yield | -9.53% |
| Earnings Yield | -5.50% |
| FCF Yield | -4.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 23, 2007. It was a forward split with a ratio of 4.
| Last Split Date | Mar 23, 2007 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |